AKT2 and cancer: Several reports have described the overexpression of Akt2 in various human cancers including, prostate, ovarian, breast, and pancreatic [26–28], and thus its role in tumorigenesis [29], poor prognosis [30], and chemo- and radio-therapeutic resistance [31] in cancer patients have been reported in recent investigations.